Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04757298 · ClinicalTrials.gov registry record · NA
Optimization of a New Adaptive Intervention to Increase COVID-19 Testing
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 668
- Enrollment target
NCT04757298 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 668 participants.
The verdict
NCT04757298, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 668 participants
- Enrollment target
Study Summary
This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the North Jersey Community Research Initiative (NJCRI)
Interventions
- BEHAVIORAL Navigation Services
- BEHAVIORAL Brief Counseling
- BEHAVIORAL Critical Dialogue
- BEHAVIORAL Referral and Digital Brochure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2021-02-12 |
| Est. Completion | 2022-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04757298
The ClinicalTrials.gov registry entry for NCT04757298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 668 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Navigation Services is the first listed.
NCT04757298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04757298 about?
NCT04757298 is a clinical study titled "Optimization of a New Adaptive Intervention to Increase COVID-19 Testing". This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue amon...
What is the current status of trial NCT04757298?
This trial is currently completed. It is a NA study. The enrollment target is 668 participants. The study started on 2021-02-12. Estimated completion is 2022-10-25.
What interventions are being tested in trial NCT04757298?
The interventions under investigation include: Navigation Services (BEHAVIORAL), Brief Counseling (BEHAVIORAL), Critical Dialogue (BEHAVIORAL), Referral and Digital Brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04757298?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.